Screener
Opko Health OPK US — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the three months ended June 30, 2026 | For the three months ended June 30, 2025 | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|---|---|
| Corporate | 15 | — | 29 | — |
| $22,409 | $23,027 | $44,609 | $46,514 | |
| Revenues: | ||||
| United States | $88,809 | $114,884 | $172,313 | $231,091 |
| Ireland | 41,663 | 11,742 | 51,343 | 17,221 |
| Chile | 16,429 | 16,003 | 31,299 | 30,535 |
| Spain | 8,451 | 6,724 | 16,501 | 13,164 |
| Israel | — | 139 | (0) | 212 |
Item 1. Financial Statements
FAQ
- What is Opko Health's US — revenue?
- Opko Health (OPK) reported US — revenue of $88.81M in Q2 2026.
- How has Opko Health's US — revenue changed year-over-year?
- Opko Health's US — revenue decreased by 22.7% year-over-year, from $114.88M to $88.81M.
- What is the long-term trend for Opko Health's US — revenue?
- Over 4 years (2021 to 2025), Opko Health's US — revenue has grown at a -28.2% compound annual growth rate (CAGR), from $1.64B to $436.06M.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from the sale of goods and services within the specified geographic segment, excluding any collected sales taxes. It serves as a primary indicator of the segment's market demand and commercial performance. Monitoring this figure helps investors assess the top-line growth trajectory and the effectiveness of the company's regional sales strategy.
Ask your AI about Opko Health's us — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude